Immunotherapy: Adjuvant immune checkpoint inhibitors for everybody?
The introduction of immunotherapy with immune checkpoint inhibitors has improved outcomes in trials. In this video Professor Morgan Roupret explains the current situation regarding immunotherapy and bladder cancer: This session… read more.
